{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:15:13Z","timestamp":1777335313329,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,4]]},"DOI":"10.7759\/cureus.37097","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:45:28Z","timestamp":1680612328000},"source":"Crossref","is-referenced-by-count":2,"title":["Robotic Adrenalectomy in a Patient With Neurofibromatosis Type 1 and Pheochromocytoma"],"prefix":"10.7759","author":[{"given":"Samantha","family":"Zhan-Moodie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"America S","family":"Revere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-018-0065-4","article-title":"Pheochromocytoma and paraganglioma in neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening","volume":"4","author":"Petr EJ","year":"2018","unstructured":"Petr EJ, Else T. Pheochromocytoma and paraganglioma in neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening\r\n. Clin Diabetes Endocrinol. 2018, 4:15. 10.1186\/s40842-018-0065-4","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00197259","article-title":"Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes","volume":"88","author":"Stephens K","year":"1992","unstructured":"Stephens K, Kayes L, Riccardi VM, Rising M, Sybert VP, Pagon RA. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet. 1992, 88:279-82. 10.1007\/BF00197259","journal-title":"Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020","volume":"4","author":"Landry JP","year":"2021","unstructured":"Landry JP, Schertz KL, Chiang YJ, et al.. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open. 2021, 4:e210945. 10.1001\/jamanetworkopen.2021.0945","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe AC","year":"2014","unstructured":"Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014, 13:834-43. 10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/jem308w","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther MM","year":"1999","unstructured":"Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen's disease and pheochromocytomas. J Urol. 1999, 162:1582-6. 10.14740\/jem308w","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca L","year":"2011","unstructured":"Zinnamosca L, Petramala L, Cotesta D, et al.. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res. 2011, 303:317-25. 10.1007\/s00403-010-1090-z","journal-title":"Arch Dermatol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2019.15.2.95","article-title":"Clinical presentation and outcomes of phaeochromocytomas\/paragangliomas in neurofibromatosis type 1","volume":"15","author":"Al-Sharefi A","year":"2019","unstructured":"Al-Sharefi A, Javaid U, Perros P, et al.. Clinical presentation and outcomes of phaeochromocytomas\/paragangliomas in neurofibromatosis type 1. Eur Endocrinol. 2019, 15:95-100. 10.17925\/EE.2019.15.2.95","journal-title":"Eur Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients","volume":"150","author":"Baguet JP","year":"2004","unstructured":"Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 2004, 150:681-6. 10.1530\/eje.0.1500681","journal-title":"Eur J Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart DR","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018, 20:671-82. 10.1038\/gim.2018.28","journal-title":"Genet Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2019.100876","article-title":"Bilateral biochemically silent pheochromocytoma, not silent after all","volume":"24","author":"El-Doueihi RZ","year":"2019","unstructured":"El-Doueihi RZ, Salti I, Maroun-Aouad M, El Hajj A. Bilateral biochemically silent pheochromocytoma, not silent after all. Urol Case Rep. 2019, 24:100876. 10.1016\/j.eucr.2019.100876","journal-title":"Urol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2017.08.002","article-title":"Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1","volume":"162","author":"Butz JJ","year":"2017","unstructured":"Butz JJ, Yan Q, McKenzie TJ, et al.. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1. Surgery. 2017, 162:1259-69. 10.1016\/j.surg.2017.08.002","journal-title":"Surgery"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148769-robotic-adrenalectomy-in-a-patient-with-neurofibromatosis-type-1-and-pheochromocytoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:31Z","timestamp":1707508651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148769-robotic-adrenalectomy-in-a-patient-with-neurofibromatosis-type-1-and-pheochromocytoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.37097","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}